EverQuote
EVER
19.39
0.00
0.00%
EverQuote
US · EVER
#3533 by market cap
Listed 2018
19.39
0.00
0.00%
Live - 5344 symbols - heartbeat 212s ago
· 2026-10-08 04:38
Pre-market
19.39
0.00%
After-hours
19.39
0.00%
- Market cap
- 683.30M
- P/E (TTM)i
- 6.32
- P/Bi
- 2.66
- EPSi
- 2.63
- Div yieldi
- 0.00%
- 52W posi
- 37%
Reader sentiment
Are you bullish or bearish on EVER?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.67, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +38.45% YoY
Margins
- Gross margin
- 97.20%
- Operating margin
- 9.61%
- Net margin
- 14.34%
Key ratios & quality
- Altman Z-Scorei
- 7.67
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 163.35M | 248.81M | 346.94M | 418.52M | 404.13M | 287.92M | 500.19M | 692.52M |
| Gross profit | 151.67M | 232.91M | 325.56M | 394.57M | 380.15M | 265.47M | 479.27M | 673.15M |
| Selling & admin expenses | 151.41M | 219.52M | 305.32M | 379.69M | 377.36M | 266.43M | 417.96M | 575.07M |
| Research & development | 14.17M | 20.21M | 29.66M | 35.73M | 31.71M | 27.59M | 29.55M | 31.50M |
| Operating profit | -13.91M | -6.82M | -9.42M | -20.86M | -28.92M | -28.56M | 31.75M | 66.57M |
| Pretax profit | -13.79M | -7.12M | -11.20M | -21.94M | -24.42M | -50.71M | 34.01M | 61.82M |
| Tax | -- | 0 | 0 | -2.51M | 0 | 577.00K | 1.84M | -37.49M |
| Net profit | -13.79M | -7.12M | -11.20M | -19.43M | -24.42M | -51.29M | 32.17M | 99.31M |
| Basic EPS | -3 | 0 | 0 | -1 | -1 | -2 | 1 | 3 |
| Diluted EPS | -3.03 | -0.28 | -0.41 | -0.67 | -0.77 | -1.54 | 0.88 | 2.63 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 166.63M | 156.63M | 173.94M | 195.32M | 190.85M | 195.09M |
| Gross profit | 161.25M | 151.79M | 169.23M | 190.88M | 186.59M | 190.73M |
| Selling & admin expenses | 137.87M | 129.52M | 143.74M | 163.95M | 154.62M | 157.81M |
| Research & development | 7.49M | 7.77M | 7.94M | 8.30M | 8.55M | 9.43M |
| Operating profit | 15.90M | 14.50M | 17.54M | 18.63M | 23.42M | 23.49M |
| Pretax profit | 8.67M | 15.06M | 18.52M | 19.57M | 24.36M | 24.51M |
| Tax | 684.00K | 363.00K | -345.00K | -38.19M | 5.69M | 5.32M |
| Net profit | 7.99M | 14.70M | 18.87M | 57.76M | 18.67M | 19.19M |
| Basic EPS | 0 | 0 | 1 | 2 | 1 | 1 |
| Diluted EPS | 0.21 | 0.39 | 0.50 | 1.54 | 0.51 | 0.53 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 60.55M | 85.33M | 97.40M | 84.69M | 80.97M | 69.24M | 171.78M | 256.29M |
| Cash & ST investments | 41.63M | 46.05M | 42.87M | 34.85M | 30.84M | 37.96M | 102.12M | 171.38M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 65.75M | 91.22M | 129.05M | 143.61M | 156.52M | 110.93M | 210.53M | 326.91M |
| Total current liabilities | 21.37M | 38.39M | 46.85M | 47.41M | 45.41M | 29.95M | 72.65M | 87.22M |
| Short-term debt | -- | -- | 2.59M | 2.70M | 2.94M | 2.09M | 1.12M | 1.20M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 22,562,000.00 | 39,451,000.00 | 58,068,000.00 | 58,482,000.00 | 49,033,000.00 | 30,018,000.00 | 75,162,000.00 | 88,873,000.00 |
| Total equity | 43.18M | 51.77M | 70.98M | 85.13M | 107.49M | 80.91M | 135.37M | 238.04M |
| Retained earnings | -99.89M | -107.01M | -118.21M | -137.65M | -162.06M | -213.35M | -181.18M | -81.87M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 194.34M | 209.47M | 223.96M | 256.29M | 257.07M | 277.69M |
| Cash & ST investments | 124.97M | 148.19M | 145.77M | 171.38M | 178.49M | 192.32M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 232.15M | 241.42M | 256.05M | 326.91M | 323.97M | 341.01M |
| Total current liabilities | 80.41M | 69.19M | 79.49M | 87.22M | 81.86M | 83.39M |
| Short-term debt | 1.16M | 1.21M | 1.24M | 1.20M | 1.28M | 1.38M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 82,645,000.00 | 71,152,000.00 | 81,119,000.00 | 88,873,000.00 | 83,105,000.00 | 84,228,000.00 |
| Total equity | 149.50M | 170.27M | 174.93M | 238.04M | 240.87M | 256.78M |
| Retained earnings | -173.19M | -158.49M | -139.62M | -81.87M | -63.20M | -44.01M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.90M | 4.41M | 10.67M | 7.19M | -15.79M | -2.83M | 66.57M | 95.38M |
| Depreciation & amortization | 1.34M | 2.19M | 3.35M | 5.07M | 5.85M | 6.20M | 5.67M | 3.81M |
| Free cash flow | -5.57M | 1.44M | 6.85M | 4.33M | -20.08M | -6.67M | 62.45M | 90.32M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 52.31M | -- | 0 | 0 | 15.00M | 0 | 0 | -21.02M |
| Ending cash balance | 41.88M | 46.30M | 43.12M | 35.10M | 30.84M | 37.96M | 102.12M | 171.38M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 23.31M | 25.30M | 19.77M | 27.01M | 29.60M | 24.32M |
| Depreciation & amortization | 1.22M | 918.00K | 811.00K | 861.00K | 785.00K | 971.00K |
| Free cash flow | 22.17M | 23.84M | 18.47M | 25.85M | 28.06M | 22.76M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -21.02M | 0 | -19.85M | -9.15M |
| Ending cash balance | 124.97M | 148.19M | 145.77M | 171.38M | 178.49M | 192.32M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -14.99 | -18.25 | -24.90 | -25.35 | -54.45 | 29.75 | 53.19 |
| ROA %i | -118.72 | -9.07 | -10.17 | -14.26 | -16.27 | -38.35 | 20.01 | 36.96 |
| ROIC %i | -- | -14.99 | -15.81 | -22.25 | -23.90 | -53.07 | 27.20 | 50.84 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -27.59 | -18.64 | -4.35 |
| EBIT margin %i | -8.32 | -2.74 | -2.72 | -4.98 | -7.16 | -9.92 | 6.35 | 9.61 |
| FCF / sales %i | -- | 0.58 | 1.97 | 1.03 | -- | -- | 12.49 | 13.04 |
| Current ratioi | 2.83 | 2.22 | 2.08 | 1.79 | 1.78 | 2.31 | 2.36 | 2.94 |
| Quick ratioi | 2.77 | 2.04 | 1.98 | 1.68 | 1.63 | 2.12 | 2.29 | 2.83 |
| Debt / assetsi | -- | 0.00 | 8.28 | 5.73 | 4.11 | 1.95 | 1.72 | 0.79 |
| LT debt / equityi | -- | -- | 11.40 | 6.50 | 3.26 | 0.09 | 1.86 | 0.58 |
| Interest coveragei | -68.30 | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | 26.55 | 40.07 | 36.84 | 17.55 | -6.03 | 6.12 | 19.67 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -31.13 | -- | -- | -- | -- | 143.47 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 32.17 | 34.34 | 36.81 | 53.19 | 56.35 | 53.61 |
| ROA %i | 20.81 | 23.31 | 24.67 | 36.96 | 39.56 | 39.31 |
| ROIC %i | 29.65 | 31.56 | 33.80 | 50.84 | 54.39 | 51.88 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.97 | 8.79 | 9.30 | 9.61 | 10.34 | 11.00 |
| FCF / sales %i | 13.02 | 14.18 | 12.97 | 13.04 | 13.42 | 12.60 |
| Current ratioi | 2.42 | 3.03 | 2.82 | 2.94 | 3.14 | 3.33 |
| Quick ratioi | 2.36 | 2.94 | 2.69 | 2.83 | 3.06 | 3.22 |
| Debt / assetsi | 1.46 | 1.31 | 1.12 | 0.79 | 0.70 | 0.57 |
| LT debt / equityi | 1.50 | 1.15 | 0.93 | 0.58 | 0.40 | 0.22 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 04:38:51 · For reference only, not investment advice and not tailored to your situation.